Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Llerena

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Science Immunology|December 13, 2024
Crystal structure of the human LAG-3-HLA-DR1-peptide complexJan Petersen, Carmen Llerena, Bagher Golzarroshan, et al.
Journal of Cell Science|December 9, 2015
PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodellingMariam Mansour, Eva Nievergall, Kristina Gegenbauer, et al.
Journal of Cell Science|October 31, 2012
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph functionLakmali Atapattu, Nayanendu Saha, Carmen Llerena, et al.
Plos One|November 25, 2014
Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growthCatherine To, Rae H Farnsworth, Mary E Vail, et al.
The Journal of Biological Chemistry|December 1, 2020
The cryo-EM structure of the endocytic receptor DEC-205Benjamin S Gully, Hariprasad Venugopal, Alex J Fulcher, et al.
International Journal of Molecular Sciences|November 13, 2025
ADAM10 Knockout from Human Glioblastoma and Colon Cancer Cells Modulates Diverse Signalling Networks and Inhibits Tumour Growth In VivoHengkang Yan, Sakshi Arora, Linda Hii, et al.
Immunity|April 26, 2023
CD4<sup>+</sup> T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunityLisa Ciacchi, Martijn D B van de Garde, Kristin Ladell, et al.
Cancer Research|August 16, 2014
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironmentMary E Vail, Carmel Murone, April Tan, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Science Immunology|August 21, 2021
A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activationRahel Frick, Lene S Høydahl, Jan Petersen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Science Immunology|December 13, 2024
Crystal structure of the human LAG-3-HLA-DR1-peptide complexJan Petersen, Carmen Llerena, Bagher Golzarroshan, et al.
Journal of Cell Science|December 9, 2015
PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodellingMariam Mansour, Eva Nievergall, Kristina Gegenbauer, et al.
Journal of Cell Science|October 31, 2012
Antibodies binding the ADAM10 substrate recognition domain inhibit Eph functionLakmali Atapattu, Nayanendu Saha, Carmen Llerena, et al.
Plos One|November 25, 2014
Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growthCatherine To, Rae H Farnsworth, Mary E Vail, et al.
The Journal of Biological Chemistry|December 1, 2020
The cryo-EM structure of the endocytic receptor DEC-205Benjamin S Gully, Hariprasad Venugopal, Alex J Fulcher, et al.
International Journal of Molecular Sciences|November 13, 2025
ADAM10 Knockout from Human Glioblastoma and Colon Cancer Cells Modulates Diverse Signalling Networks and Inhibits Tumour Growth In VivoHengkang Yan, Sakshi Arora, Linda Hii, et al.
Immunity|April 26, 2023
CD4<sup>+</sup> T cell-mediated recognition of a conserved cholesterol-dependent cytolysin epitope generates broad antibacterial immunityLisa Ciacchi, Martijn D B van de Garde, Kristin Ladell, et al.
Cancer Research|August 16, 2014
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironmentMary E Vail, Carmel Murone, April Tan, et al.
The Journal of Experimental Medicine|August 10, 2016
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growthLakmali Atapattu, Nayanendu Saha, Chanly Chheang, et al.
Science Immunology|August 21, 2021
A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activationRahel Frick, Lene S Høydahl, Jan Petersen, et al.
Pageof 1